Table 7.
Desired and achievable in vitro two-phase parameters to make dissolution test physiological for valproic acid, ondansetron, ibuprofen and felodipine based on in vivo properties and performance
|
In vivo properties/ performance |
In vitro drug properties |
Desired in vitro parameters |
Achievable in vitro parameters | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| F a a |
kaa × 104 |
Doseb | V c | Dose /V |
clogD 6.5d |
Dae × 106 |
PIf × 104 |
kpg × 104 |
AI/ Vah |
F
o, ∞ i |
M
T
/ V a j |
Vessel capacity |
Depth below impellerk |
Vessel AI/Val |
V a m |
kpn × 104 |
V o o | β | Dosep | |
| Actual | Decon. | Theo. | Est. | Est. | Calc. | Est. | Est. | Based on ka |
Est. | Based on dose/V |
Based on USP standard |
Req. | Est. | Req. | Req. | |||||
| Drug name | s−1 | mg | ml | mg/ml | - | cm2/s | cm/s | s−1 | cm−1 | - | mg/ml | ml | cm | cm−1 | ml | s−1 | ml | - | mg | |
| Valproic acid (BCS II) | 1 | 11.5 | 250 | 100 | 2.50 | 1.43 | 8.87 | 22.1 | 11.5 | 0.52 | 0.98 | 2.50 | 100 | 1.0 | 0.47 | 27 | 10.4 | 50 | 0.02 | 68 |
| Ondansetron (BCS I or III) | 1 | 5.3 | 8 | 100 | 0.08 | 1.65 | 6.63 | 18.4 | 5.3 | 0.29 | 0.98 | 0.08 | 1000 (USP II) | 2.5 | 0.26 | 302 | 4.8 | 338 | 0.02 | 24 |
| Ibuprofen (BCS II) | 1 | 7.4 | 200 | 100 | 2.00 | 2.19 | 7.50 | 23.6 | 7.4 | 0.31 | 0.98 | 2.00 | 1000 (USP II) | 2.5 | 0.26 | 302 | 6.1 | 97 | 0.02 | 604 |
| Felodipine (BCS II) | 1 | 12.5 | 5 | 100 | 0.05 | 3.41 | 6.10 | 20.3 | 12.5 | 0.62 | 0.98 | 0.05 | Not possible unless depth below impeller is decreased to 2 cm and smaller vessel used | |||||||
From reference [36].
Arbitrarily chose one of the marketed oral unit doses.
Average human fasted intestinal volume.
Determined using reference [26].
Estimated using Hayduk-Laudie (H-L) method.
Estimated using Equation (10) assuming ha = ho = 30μm.
Equal to ka.
Calculated using Equation (24).
Value should ideally be equal or close to Fa in vivo. 0.98 was chosen due to vessel size constraints.
Equal to Dose/V.
The standard set-up for distance from bottom of vessel to bottom of impeller is 2.5 cm for the 1000 ml USP 2 vessel. 1 cm chosen for 100 ml vessel, which should accommodate a tablet or capsule.
From Table 1. Value set by apparatus geometry and minimum or maximum practical volume of media.
Volume required to achieve AI/Va.
Equal to estimated PI times the actual AI/Va.
Volume required to achieve desired Fo,∞ based on cLogD 6.5 and Va.
Equal to desirable MT/Va* achievable Va.